NCT00131014
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT00131014
NCT06801002
NCT06988020
NCT07365306
NCT04028531
NCT06421987
NCT05245656
NCT04989621
NCT07547007